Sarcoma: all 1,691 studies
Page 13 of 17. Open to participants first (393), then studies with results posted, then the rest; newest registration first within each.
- Endostar + GT in Pulmonary Metastases of Soft Tissue SarcomaStatus unknownNCT01812018Phase 2
- Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid TumorsStatus unknownNCT01807468Phase 2
- Dendritic Cell Vaccine for Children and Adults With SarcomaCompletedNCT01803152Phase 1
- Biomarker Differences in Samples From Patients With Undifferentiated SarcomasCompletedNCT01802125
- Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing SarcomaWithdrawnNCT01795430Not applicable
- Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young AdultsStatus unknownNCT01780779
- Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast CancerCompletedNCT01764802Phase 2
- Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast CancerCompletedNCT01764789Not applicable
- Strategies to Improve Kaposi Sarcoma (KS) Outcomes in ZimbabweCompletedNCT01764360Not applicable
- A Study of Selumetinib in Patients With Kaposi's SarcomaTerminatedNCT01752569Phase 1/2
- Bevacizumab/Doxorubicin/Radiation for SarcomaActive, not recruitingNCT01746238Phase 1
- Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma PatientsWithdrawnNCT01734863Phase 3
- Docetaxel, Gemcitabine and Pazopanib as Treatment for Soft Tissue SarcomaCompletedNCT01719302Phase 1/2
- Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced SarcomasCompletedNCT01716689Phase 2
- Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young AdultsCompletedNCT01696669Phase 2
- Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue SarcomaCompletedNCT01684449Phase 1/2
- Effects of Preoperative Physical Therapy in Patients With Lower Extremity MalignancyCompletedNCT01674101Not applicable
- Biomarkers in Patients With Advanced RhabdomyosarcomaCompletedNCT01668095
- Ferumoxytol-Enhanced MRI in Adult/Pedi SarcomasWithdrawnNCT01663090Not applicable
- Study of 124I-NM404 in Advanced Solid MalignanciesTerminatedNCT01662284
- Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological CancerCompletedNCT01652794Phase 1
- Therapeutic Response of Patients With Soft Tissue Sarcoma According to CHOI CriteriaCompletedNCT01650077
- Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are MetastaticCompletedNCT01643278Phase 1
- Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionCompletedNCT01638533Phase 1
- Cathepsin Activatable Fluorescent ProbeCompletedNCT01626066Phase 1
- Phase II Study Evaluating Strategies of Lung Surveillance of Patients Operated of High Grade Soft Tissue SarcomaTerminatedNCT01612481Phase 2
- A Study of RO5045337 in Combination With Doxorubicin in Patients With Soft Tissue SarcomaCompletedNCT01605526Phase 1
- Contribution of F18-FDG PET/CT to the Early Assessment of Pazopanib Therapy Efficacy in Advanced Soft Tissue SarcomaStatus unknownNCT01594203
- Aerosolized Aldesleukin in Treating Patients With Lung MetastasesActive, not recruitingNCT01590069Phase 1/2
- Pilot Study: Dynamic Contrast-enhanced Magnetic Resonance Imaging(DCE-MRI)for Assessing Tumor Vascularity and Permeability in Soft Tissue Sarcoma Treated With Preoperative Radiotherapy Followed by Surgical ResectionCompletedNCT01575951Not applicable
- Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue SarcomasCompletedNCT01567046
- Trial of Neoadjuvant Intensity-Modulated Radiation Therapy Followed by Surgery and Intraoperative Radiation Therapy in Resectable Retroperitoneal Soft Tissue Sarcoma (RETRO-WTS)CompletedNCT01566123Phase 1/2
- Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseTerminatedNCT01552434Phase 1
- Preoperative Radiotherapy for Sarcomas of the Extremities With Intensity-Modulation, Image-Guidance and Small Safety-marginsStatus unknownNCT01552239Phase 2
- Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryCompletedNCT01548482Phase 1
- Study of Preoperative Therapy With Pazopanib (Votrient®) to Treat High-risk Soft Tissue SarcomaTerminatedNCT01543802Phase 2
- CREATE: Cross-tumoral Phase 2 With CrizotinibCompletedNCT01524926Phase 2
- Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid TumorsCompletedNCT01518413Phase 1
- Auto Transplant for High Risk or Relapsed Solid or CNS TumorsCompletedNCT01505569Not applicable
- Predictive Study of Radiation Induced SarcomaCompletedNCT01504360Not applicable
- Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue SarcomaCompletedNCT01498835Phase 1
- Eltrombopag for the Prevention of Chemotherapy Induced ThrombocytopeniaTerminatedNCT01491594Phase 1
- Sarcoma Database at KFSH&RCStatus unknownNCT01490970
- Biomarkers in Tissue Samples From Patients With Ewing SarcomaCompletedNCT01480518
- Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid TumorsTerminatedNCT01479023Phase 1
- Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By SurgeryCompletedNCT01477021Phase 1
- First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10TerminatedNCT01469975Phase 1
- Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant CancerCompletedNCT01445379Phase 1
- A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue SarcomaCompletedNCT01440088Phase 3
- Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and CholangiocarcinomaCompletedNCT01438554Phase 1
- Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous BypassCompletedNCT01433302
- Studying Biomarkers in Samples From Patients With RhabdomyosarcomaCompletedNCT01433237
- NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma of the ExtremityCompletedNCT01433068Phase 1
- Studying Genes in Samples From Younger Patients With Desmoplastic Small Round Cell Tumor Registered on COG-D9902 or COG-ABTR01B1CompletedNCT01430637
- YONDELIS (Trabectedin) Single Patient Compassionate Use / Expanded AccessNo longer availableNCT01427582
- DNA Tests in Detecting Disseminated Disease in Tumor, Blood, and Bone Marrow Samples From Patients With RhabdomyosarcomaCompletedNCT01419509
- NHS-IL12 for Solid TumorsCompletedNCT01417546Phase 1
- HYPAZ: Hypertension Induced by PazopanibTerminatedNCT01392352Phase 2
- High Precision RT For Soft-Tissue SarcomaCompletedNCT01389050Phase 2
- CT-011 and p53 Genetic Vaccine for Advanced Solid TumorsWithdrawnNCT01386502Phase 1
- Neoadjuvant and Adjuvant Chemotherapy in High-risk Soft Tissue SarcomaCompletedNCT01382030Phase 2
- Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.Status unknownNCT01380275Phase 2
- Doxorubicin With or Without Sildenafil, With Analysis of Cardiac MarkersCompletedNCT01375699Phase 1
- Biomarker in Tissue Samples From Patients With Ewing SarcomaCompletedNCT01365949
- Biomarkers in Samples From Young Patients With Soft Tissue SarcomaCompletedNCT01342783
- Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor RemovalTerminatedNCT01341496Phase 1
- A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS)Status unknownNCT01337401Phase 2
- Aflac ST0901 CHOANOME - Sirolimus in Solid TumorsCompletedNCT01331135Phase 1
- Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or MediastinumTerminatedNCT01313429Phase 1
- Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant RadiotherapyCompletedNCT01308034Phase 1
- Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue SarcomaCompletedNCT01303094Phase 2
- Study in Patients With Advanced Soft Tissue Sarcoma (STS) After Failure of Anthracyclines and/or IfosfamideCompletedNCT01299506
- Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue SarcomaWithdrawnNCT01296659Phase 1
- A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens AloneCompletedNCT01288573Phase 1/2
- Monitoring Chemotherapy Response of Soft Tissue Sarcomas and Osteosarcomas Using Diffuse Optical Spectroscopic ImagingCompletedNCT01263405
- Dose Escalation Study of TriN2755 in Advanced Solid Tumors and SarcomasStatus unknownNCT01259518Phase 1
- Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural MesotheliomasTerminatedNCT01258868Phase 1
- Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and SarcomaCompletedNCT01241162Phase 1
- Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation TherapyActive, not recruitingNCT01223248Phase 3
- To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory CancerCompletedNCT01222780Phase 1
- Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue SarcomasStatus unknownNCT01216839Phase 2
- Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological CancerCompletedNCT01216813
- Study of Blood Samples From Patients With Ewing Sarcoma and Their RelativesCompletedNCT01210209
- Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue SarcomaTerminatedNCT01204450Phase 1
- Gemcitabine,Vincristine and Cisplatin as Second Line Combination Therapy in Patients With SarcomaStatus unknownNCT01192633Phase 2
- Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell TumorActive, not recruitingNCT01189643Early Phase 1
- Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue SarcomaTerminatedNCT01189253Phase 2/3
- New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and NeuroblastomaWithdrawnNCT01174537Phase 1/2
- Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal CancerCompletedNCT01170299Not applicable
- Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric PatientsCompletedNCT01169584Phase 1
- Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue SarcomaTerminatedNCT01168791Phase 3
- Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1
- Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural MesotheliomasTerminatedNCT01143545Phase 1
- A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue SarcomasCompletedNCT01140737Phase 2
- Chemotherapy-induced Symptoms in Sarcoma Patients and the Impact of Tumor BurdenCompletedNCT01136824
- Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment FailureCompletedNCT01136499Phase 2
- B-Receptor Signaling in CardiomyopathyCompletedNCT01135849
- A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and LymphomasCompletedNCT01132911Phase 1
- A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid TumorsWithdrawnNCT01130623Phase 1
- Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology GroupActive, not recruitingNCT01117168